CClinicalTrials.gg
CompletedNCT01938066Updated Apr 21, 2016Results posted

Procellera and Negative Pressure Therapy for Acute Wounds

An interventional study of Procellera and negative pressure therapy in Wound, sponsored by Gayle Gordillo. Completed at 1 site in United States. Open to participants aged 18 Years to 69 Years. Per ClinicalTrials.gov, last updated 2016-04-21.

Sponsored by Gayle Gordillo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 69 Years
Sex
All
01

Study summary

The purpose of this study is to determine if Procellera speeds wound healing. The study will examine colonization (bacterial growth), pain and pain medication and reduced cost of care by using Procellera (an antimicrobial agent) under Negative Pressure Therapy placed on the wound after abdominal wall surgery. Procellera is a single layer dressing that helps to kill germs that cause infections. Negative Pressure Therapy is a vacuum device with a sponge that is placed in your wound to help heal the wound faster.

Read the detailed description

The study will consent 30 patients undergoing surgery through the abdominal wall and the skin incision will intentionally be left open. Subjects will be randomized using a random number generator. Each number will be placed in an envelope numbered 1-30. Arm 1 will be even numbers and Arm 2 will be odd numbers. A researcher not affiliated with the study will generate the numbers and place them in the envelopes. Arm 1 will place fifteen subjects on Negative Pressure Therapy Only and Arm 2 will place fifteen subjects on Negative Pressure and Procellera. Arm 1 (Negative Pressure Only) will have their dressing changed 3 times per week which is the standard of care for Negative Pressure Therapy. Arm 2 (Negative Pressure Therapy and Procellera) will have their dressing changed every 5 days. Arm 1 and 2 will have a tissue specimen taken on the 5th day only. The tissue will be taken from debrided material and sent for culture. The Negative Pressure Therapy Sponge, which is discarded after each dressing change, will be collected, lavaged with saline and the cells will be examined for macrophage function and the wound fluid will be tested for inflammation response. Photographs, wound measurements, pain scale and pain medication will also be completed at each dressing change. We will check the progress of the wound along with your surgeon during the subject's 30 day surgical follow up in the surgeon's office. The wound will be measured (if not healed), photograph's taken and their pain level assessed.

02

Conditions studied

  • Wound

Browse trials for

Keywords

  • procellera
03

In context

Wounds and Injuries

5,056 studies on the registry are indexed under Wounds and Injuries; 861 are open to participants now.

This study's enrollment of 30 is below the median of 52 across 3,239 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

Gayle Gordillo is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years old that are undergoing abdominal wall surgery

Exclusion criteria

Exclusion Criteria:

  • Below 18 years old and not having abdominal wall surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Negative Pressure with Procellera

    Arm 2 is Negative Pressure Therapy and Procellera Dressing under the sponge dressing of the Negative Pressure Therapy. The dressing will be changed at the end of 5 days. This is the intervention arm of the study.

    Device: Procellera · Device: negative pressure therapy

  • Sham comparator
    Negative Pressure Therapy only

    Arm 1 is Negative Pressure Therapy only with no Procellera Dressing and the dressing is changed every other day per standard of care when you use Negative Pressure Therapy with no dressing underneath the sponge.

    Device: negative pressure therapy

Interventions

  • DeviceProcellera

    bioelectric wound dressing

  • Devicenegative pressure therapy
06

What researchers measure

Primary outcomes

  1. Wound Infection

    At the end of 5 days all subjects will get a Culture and Sensitivity to see if they have an infection or what type of infection they have in the wound

    Time frame: At the end of 5 days

Secondary outcomes

  1. Amount of Pain Medication Used (Morphine)

    will measure the amount of pain medication used (morphine)

    Time frame: 5 days

07

Results

Posted Apr 21, 2016

Participant flow

Participant flow — Overall Study
MilestoneNegative Pressure With ProcelleraNegative Pressure Therapy Only
Started1515
Completed1413
Not completed12

Outcome measures

PrimaryWound Infection

At the end of 5 days all subjects will get a Culture and Sensitivity to see if they have an infection or what type of infection they have in the wound

Time frame:
At the end of 5 days
Reported as:
Number · participants
Wound Infection
participantsNegative Pressure With ProcelleraNegative Pressure Therapy Only
Wound Infection1312
SecondaryAmount of Pain Medication Used (Morphine)

will measure the amount of pain medication used (morphine)

Time frame:
5 days
Reported as:
Mean · mg
Amount of Pain Medication Used (Morphine)
mgNegative Pressure With ProcelleraNegative Pressure Therapy Only
Amount of Pain Medication Used (Morphine)139.29 ± 116.05178.55 ± 147.28

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Negative Pressure With Procellera—0/14 (0%)0/14 (0%)
Negative Pressure Therapy Only—0/13 (0%)0/13 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Negative Pressure With ProcelleraNegative Pressure Therapy OnlyTotal
<=18 years000
Between 18 and 65 years11314
>=65 years31013
Age, Continuous
Age, Continuous(years)Negative Pressure With ProcelleraNegative Pressure Therapy OnlyTotal
Mean54.7 ± 1058.3 ± 1256.8 ± 11
Sex: Female, Male
Sex: Female, Male(Participants)Negative Pressure With ProcelleraNegative Pressure Therapy OnlyTotal
Female7714
Male7613
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Negative Pressure With ProcelleraNegative Pressure Therapy OnlyTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American617
White81220
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Negative Pressure With ProcelleraNegative Pressure Therapy OnlyTotal
United States141327
Weight
Weight(lbs)Negative Pressure With ProcelleraNegative Pressure Therapy OnlyTotal
Mean215.5 ± 66.2202.1 ± 85.1210.6 ± 74.3
08

Study locations

1 site
  • University Hosptial East
    Columbus, Ohio 43205, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01938066
Lead sponsor
Gayle Gordillo
Collaborators
Vomaris Innovations
Responsible party
Gayle Gordillo (Associate Professor, Ohio State University) — Sponsor-investigator
First posted
Sep 10, 2013
Start date
Jul 2013
Primary completion
Sep 2014
Completion
Dec 2014
Results posted
Apr 21, 2016
Last update
Apr 21, 2016

Study contacts

Gayle M Gordillo, MD
principal investigator · Ohio State University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion